Publicacions en què col·labora amb Germán M. Perdomo Hernández (9)

2024

  1. Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation (Diabetologia, (2022), 65, 8, (1375-1389), 10.1007/s00125-022-05729-y)

    Diabetologia

2022

  1. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation

    Diabetologia, Vol. 65, Núm. 8, pp. 1375-1389

2021

  1. Modulation of insulin sensitivity by insulin-degrading enzyme

    Biomedicines, Vol. 9, Núm. 1, pp. 1-38

2020

  1. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice

    Metabolism: Clinical and Experimental, Vol. 113

  2. Intestinal fructose and glucose metabolism in health and disease

    Nutrients, Vol. 12, Núm. 1

2019

  1. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity

    American journal of physiology. Endocrinology and metabolism, Vol. 317, Núm. 5, pp. E805-E819

2018

  1. Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment

    Histology and histopathology, Vol. 33, Núm. 11, pp. 1167-1180

  2. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice

    Metabolism: Clinical and Experimental, Vol. 88, pp. 1-11

2015

  1. Protective effects of epoxypukalide on pancreatic β-cells and glucose metabolism in STZ-induced diabetic mice

    Islets, Vol. 7, Núm. 2, pp. e1078053